down arrow

Portage Biotech, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VGG7185A1286
USD
1.71
0.04 (2.4%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1.481.72

52 Week

1.4815.82
Valuation
Technical
Day's Volume

CASH

72.47 k

Shareholding (Sep 2024)

FII

0.19%

Held by 11 FIIs

DII

99.69%

Held by 0 DIIs

Promoter

0.00%

How big is Portage Biotech, Inc.?

22-Jun-2025

As of Jun 18, Portage Biotech, Inc. has a market capitalization of 6.43 million and reported net sales of 0.00 million, with a net profit of -67.31 million over the last four quarters. The balance sheet shows shareholder's funds of 4.02 million and total assets of 7.78 million.

As of Jun 18, Portage Biotech, Inc. has a market capitalization of 6.43 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, with a consolidated net profit of -67.31 million during the same period.<BR><BR>As of Mar 24, the balance sheet shows shareholder's funds of 4.02 million and total assets amounting to 7.78 million.

Read More

What does Portage Biotech, Inc. do?

22-Jun-2025

Portage Biotech, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $1 million and a market cap of $6.43 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -386.34%.

Overview:<BR>Portage Biotech, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: -1 Million (Quarterly Results - Sep 2024) <BR>Market cap: USD 6.43 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.24 <BR>Return on Equity: -386.34% <BR>Price to Book: 4.60 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Portage Biotech, Inc. technically bullish or bearish?

20-Sep-2025

As of August 27, 2025, Portage Biotech, Inc. has a mildly bullish trend, supported by a positive daily moving average, although mixed signals from MACD and Bollinger Bands indicate varying performance, with a recent 15.14% gain contrasting a -36.63% return over the past year compared to the S&P 500's 17.14%.

As of 27 August 2025, the technical trend for Portage Biotech, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a daily moving average that indicates a positive short-term outlook, despite mixed signals from the MACD and Bollinger Bands across different time frames. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. The overall performance shows a stark contrast in returns; the stock has gained 15.14% over the past week compared to a modest 1.05% gain in the S&P 500, but it has underperformed significantly over longer periods, with a 1-year return of -36.63% versus the S&P 500's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 13 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.24

stock-summary
Return on Equity

540.10%

stock-summary
Price to Book

-13.42

Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2024)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-74.89%
0%
-74.89%
6 Months
-77.82%
0%
-77.82%
1 Year
-57.04%
0%
-57.04%
2 Years
-93.67%
0%
-93.67%
3 Years
-98.83%
0%
-98.83%
4 Years
-99.35%
0%
-99.35%
5 Years
-99.34%
0%
-99.34%

Portage Biotech, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Portage Biotech, Inc. technically bullish or bearish?

As of 27 August 2025, the technical trend for Portage Biotech, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a daily moving average that indicates a positive short-term outlook, despite mixed signals from the MACD and Bollinger Bands across different time frames. The weekly MACD is mildly bearish, while the monthly MACD is mildly bullish. The overall performance shows a stark contrast in returns; the stock has gained 15.14% over the past week compared to a modest 1.05% gain in the S&P 500, but it has underperformed significantly over longer periods, with a 1-year return of -36.63% versus the S&P 500's 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-151.03%
EBIT to Interest (avg)
-9.55
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.24
Sales to Capital Employed (avg)
0
Tax Ratio
2.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
22.93%
ROCE (avg)
0
ROE (avg)
267.52%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.74
EV to EBIT
-0.65
EV to EBITDA
-0.66
EV to Capital Employed
-7.69
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-386.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 2 Schemes (0.12%)

Foreign Institutions

Held by 11 Foreign Institutions (0.19%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2024 is 73.08% vs -372.73% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-5.90",
          "chgp": "72.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-0.10",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-5.20",
          "chgp": "73.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 90.98% vs 27.98% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.40",
          "val2": "-18.20",
          "chgp": "59.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "-64.50",
          "chgp": "100.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.80",
          "val2": "-75.40",
          "chgp": "90.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'24 - YoYstock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.60
-5.90
72.88%
Interest
0.00
0.00
Exceptional Items
0.20
-0.10
300.00%
Consolidate Net Profit
-1.40
-5.20
73.08%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2024 is 73.08% vs -372.73% in Sep 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-7.40
-18.20
59.34%
Interest
0.00
0.00
Exceptional Items
0.60
-64.50
100.93%
Consolidate Net Profit
-6.80
-75.40
90.98%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 90.98% vs 27.98% in Mar 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About Portage Biotech, Inc. stock-summary
stock-summary
Portage Biotech, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."